Skip to content
Search

Latest Stories

DHSC grants final November price concessions

The Pharmaceutical Services Negotiating Committee has announced that the Department of Health and Social Care (DHSC) has granted final price concessions to further items for the month of November 2021.

DrugPack sizePrice Concession
Co-amilozide 5mg/50mg tablets28£8.98
Co-dydramol 10mg/500mg tablets100£6.19
Co-dydramol 10mg/500mg tablets30£1.86
Omeprazole 10mg/5ml oral suspension sugar free75£106.46
Omeprazole 20mg/5ml oral suspension sugar free75£206.00
Prednisolone 5mg soluble tablets30£10.35
Simvastatin 20mg/5ml oral suspension sugar free150£173.89
Simvastatin 40mg/5ml oral suspension sugar free150£250.63
Sulfasalazine 500mg gastro-resistant tablets112£23.12
Sulfasalazine 500mg tablets112£21.35
Topiramate 100mg tablets60£8.09
Topiramate 25mg tablets60£2.89
Topiramate 50mg tablets60£3.52
Trazodone 100mg capsules56£3.50
Trazodone 150mg tablets28£3.31

The DHSC previously announced (26.11.2021) the following list of price concessions:


DrugPack sizePrice Concession
Amisulpride 50mg tablets60£2.99
Donepezil 1mg/ml oral solution sugar free150£81.23
Ivabradine 5mg tablets56£7.87
Lercanidipine 20mg tablets28£3.04
Metformin 500mg/5ml oral solution sugar free150£36.15
Mirtazapine 15mg/ml oral solution sugar free66£97.89
Orphenadrine 50mg/5ml oral solution sugar free150£87.09
Procyclidine 2.5mg/5ml oral solution sugar free150£37.39
Procyclidine 5mg/5ml oral solution sugar free150£55.61
Promazine 25mg/5ml oral solution150£60.19
Promazine 50mg/5ml oral solution150£75.36
Quetiapine 20mg/ml oral suspension sugar free150£166.31
Ramipril 2.5mg/5ml oral solution sugar free150£164.12
Ropinirole 1mg tablets84£56.71
Sodium fluoride 0.05% mouthwash sugar free250£1.57
Sulfasalazine 250mg/5ml oral suspension sugar free500£94.22
Tamoxifen 10mg/5ml oral solution sugar free150£74.52
Timolol 0.25% eye drops5£3.73
Trihexyphenidyl 5mg/5ml oral solution200£82.54
Trimethoprim 100mg tablets28£2.10
Warfarin 1mg/ml oral suspension sugar free150£156.07

The DHSC previously announced (19.11.2021) the following list of price concessions:

DrugPack sizePrice Concession
Celecoxib 100mg capsules60£1.80
Celecoxib 200mg capsules30£1.75
Cinnarizine 15mg tablets84£3.97
Clomipramine 10mg capsules28£2.76
Clomipramine 25mg capsules28£4.85
Clomipramine 50mg capsules28£8.25
Enalapril 10mg tablets28£5.29
Enalapril 5mg tablets28£7.15
Fludrocortisone 100microgram tablets30£11.20
Lamotrigine 5mg dispersible tablets sugar free28£8.35
Lansoprazole 30mg orodispersible tablets28£5.18
Lercanidipine 10mg tablets28£2.99
Loratadine 5mg/5ml oral solution100£6.46
Methocarbamol 750mg tablets100£12.95
Naftidrofuryl 100mg capsules84£7.79
Nitrofurantoin 50mg capsules30£10.49
Orlistat 120mg capsules84£24.22
Pioglitazone 30mg tablets28£2.70
Pioglitazone 45mg tablets28£2.70
Timolol 0.5% eye drops5£3.77
Tolbutamide 500mg tablets28£25.75
Tolterodine 1mg tablets56£3.46
Tolterodine 2mg tablets56£4.82
Trazodone 50mg capsules84£3.45
Trimethoprim 50mg/5ml oral suspension sugar free100£10.75
Ursodeoxycholic acid 250mg capsules60£10.27

A price concession only applies for the month in which it is granted. No additional prescription endorsement are required as the new price is automatically applied by the NHS BSA to all items submitted for payment in the same month for which a price concession is granted.

Contractors can find information and learn about the process involved on PSNC’s website.

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less